Walgreens Boots Alliance (NASDAQ:WBA) Issues Earnings Results

Walgreens Boots Alliance (NASDAQ:WBA) released its earnings results on Wednesday. The pharmacy operator reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.03 by $0.19, MarketWatch Earnings reports. The firm had revenue of $36.31 billion during the quarter, compared to the consensus estimate of $35.01 billion. Walgreens Boots Alliance had a return on equity of 18.33% and a net margin of 0.33%. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.37 earnings per share.

Shares of NASDAQ WBA traded down $0.13 during mid-day trading on Friday, reaching $45.13. The company had a trading volume of 432,921 shares, compared to its average volume of 11,145,039. Walgreens Boots Alliance has a twelve month low of $33.36 and a twelve month high of $56.80. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.32 and a current ratio of 0.67. The stock has a market capitalization of $38.99 billion, a PE ratio of 91.50, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The stock’s 50 day moving average is $40.18 and its 200-day moving average is $39.23.

The company also recently announced a quarterly dividend, which was paid on Friday, December 11th. Shareholders of record on Thursday, November 19th were paid a dividend of $0.4675 per share. This represents a $1.87 annualized dividend and a yield of 4.14%. The ex-dividend date was Wednesday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 39.45%.

A number of research firms have weighed in on WBA. Truist Financial upped their target price on Walgreens Boots Alliance from $40.00 to $44.00 in a research report on Tuesday. Mizuho cut their price objective on Walgreens Boots Alliance from $43.00 to $37.00 and set a “neutral” rating for the company in a research report on Friday, September 11th. Truist increased their price objective on Walgreens Boots Alliance from $44.00 to $48.00 in a research report on Friday. The Goldman Sachs Group cut their price objective on Walgreens Boots Alliance from $37.00 to $33.00 and set a “sell” rating for the company in a research report on Tuesday, October 6th. Finally, ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Tuesday, December 1st. Four analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $42.31.

In other news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the company’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total value of $207,750.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 16.91% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Read More: What are economic reports?

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.